CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Pittsburgh, Pennsylvania, United States and 67 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Scottdale, Pennsylvania, United States and 130 other locations
and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 103 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 372 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Pittsburgh, Pennsylvania, United States and 419 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Pittsburgh, Pennsylvania, United States and 248 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 143 other locations
safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 134 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 362 other locations
MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...
Phase 3
Pittsburgh, Pennsylvania, United States and 92 other locations
Clinical trials
Research sites
Resources
Legal